Literature DB >> 30217319

Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction.

Jianqiao Cao1, Ting Yang2, Guanhua Wang3, Hongfei Zhang4, Yanjie You5, Jing Chen4, Jingwen Yang2, Wenjun Yang6.   

Abstract

OBJECTIVE: To explore the clinicopathological features and prognostic factors of 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction (AEG).
METHODS: In total, 734 patients were confirmed to have AEG by gastroscopy and pathology at the General Hospital of Ningxia Medical University between January 2002 and December 2012. Univariate and multivariate analyses of demographic, clinicopathological, and prognostic data were performed.
RESULTS: In total, 734 AEG patients underwent surgical intervention, including 169 Hui patients and 565 Han patients. The male to female ratio was 9.5:1 in Hui patients and 6.4:1 in Han patients, and the average age in both groups was approximately 61 years. The Han patients were more likely to have a cigarette smoking history and an alcohol consumption history than the Hui patients (58.8% vs. 29.4%, p = 0.000; 45.8% vs. 14.6%, p = 0.000). The 5-year survival rate in the Hui and Han patients was 54.3% and 39.9%, respectively (p = 0.024). Age (p = 0.005), sex (p = 0.015), pathologic T stage (p = 0.056), pathologic N stage (p = 0.000), pathologic M stage (p = 0.001), number of resected lymph nodes (p = 0.001) and adjuvant chemoradiotherapy (p = 0.002) were significant independent prognostic factors.
CONCLUSION: The AEG patients were primarily male and elderly in both Hui and Han groups with the prognosis of Hui patients better than Han patients. Age, sex, pathologic T3-4 stage, pathologic N stage, pathologic M stage, number of resected lymph nodes, and adjuvant chemoradiotherapy were significant independent factors predictive of the prognosis of AEG in both groups.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenocarcinoma of the esophagogastric junction; Clinicopathological features; Ethnic minority; Prognosis

Mesh:

Year:  2018        PMID: 30217319     DOI: 10.1016/j.suronc.2018.07.008

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  4 in total

1.  Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.

Authors:  Yuling Zhang; Ditian Liu; Chunfa Chen
Journal:  J Gastrointest Cancer       Date:  2021-09

2.  Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.

Authors:  Zhenjiang Guo; Ning Wang; Fangzhen Liu; Qun Zhao
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.

Authors:  Zhenjiang Guo; Honghai Guo; Yuan Tian; Ze Zhang; Qun Zhao
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.

Authors:  Haitao Xu; Lianguo Zhang; Jing Miao; Shuai Liu; Hongjian Liu; Teng Jia; Qingguang Zhang
Journal:  World J Surg Oncol       Date:  2020-06-27       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.